Harish Dave

Harish Dave

Company: AUM Biosciences

Job title: CMO

Seminars:

Expert Panel Discussion: Combining Kinase Inhibitor Therapies for Supercharged Targeting 12:30 pm

Discussing multiple points of entry of oncogenic pathways to enhance targeting and therapeutic impact Redefining outcomes with combination therapies across indications, from oncology, dermatology, respiratory & autoimmune diseases Assessing the safety issues with polypharmacy of 1 or more kinases and mitigating off-target effectsRead more

day: Day Two

Rationalizing Kinase Inhibitor Combinations with Immunotherapy to Optimize Tumor Killing 12:00 pm

Harnessing the patients’ immune systems with novel kinase inhibitors to minimize side effects Assessing the key take-aways from PI3K-PD-1 dual blockade to expand to other kinase inhibitors and checkpoint inhibitors Theorizing the potential for novel kinase inhibitors to act on checkpoint inhibitor resistant cancer typesRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.